- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03375320
Testování kabozantinibu u pacientů s pokročilými pankreatickými neuroendokrinními a karcinoidními nádory
Randomizovaná, dvojitě zaslepená studie fáze III cabozantinib versus placebo u pacientů s pokročilými neuroendokrinními nádory po progresi předchozí terapie (CABINET)
This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.
Přehled studie
Postavení
Podmínky
- Neuroendokrinní nádor
- Funkční neuroendokrinní nádor pankreatu
- Neuroendokrinní novotvar plic středního stupně
- Lokálně pokročilý pankreatický neuroendokrinní nádor
- Neuroendokrinní novotvar lokálně pokročilého neresekovatelného trávicího systému
- Neuroendokrinní novotvar plic nízkého stupně
- Metastatický trávicí systém Neuroendokrinní novotvar
- Metastatický trávicí systém Neuroendokrinní nádor G1
- Metastatický pankreatický neuroendokrinní nádor
- Neuroendokrinní novotvar
- Nefunkční neuroendokrinní nádor pankreatu
- Neuroendokrinní nádor produkující serotonin pankreatu
- Lokálně pokročilý plicní neuroendokrinní novotvar
- Metastatický plicní neuroendokrinní novotvar
- Neresekabilní plicní neuroendokrinní novotvar
- Neuroendokrinní novotvar lokálně pokročilého trávicího systému
- Neuroendokrinní nádor G1 lokálně pokročilého trávicího systému
- Metastatický pankreatický neuroendokrinní novotvar
- Neresekabilní neuroendokrinní novotvar trávicího systému
- Neresekabilní neuroendokrinní tumor G1 trávicího systému
- Neresekabilní neuroendokrinní novotvar pankreatu
- Neuroendokrinní nádor plic G2
- Metastatický plicní neuroendokrinní nádor
- Neuroendokrinní nádor plic
- Neuroendokrinní nádor G2
- Metastatický neuroendokrinní novotvar brzlíku
- Neuroendokrinní nádor brzlíku
- Neresekabilní neuroendokrinní novotvar brzlíku
Detailní popis
PRIMARY OBJECTIVES:
I. To determine whether cabozantinib (cabozantinib S-malate) can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced pancreatic neuroendocrine tumors (NET) whose disease has progressed after prior therapy.
II. To determine whether cabozantinib can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
SECONDARY OBJECTIVES:
I. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
II. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
III. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced pancreatic NET using Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
IV. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced carcinoid tumors using CTCAE and PRO-CTCAE.
V. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
VI. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
OTHER OBJECTIVE:
I. Results of the primary analysis will be examined for consistency, while taking into account the stratification factors and/or covariates of baseline quality of life (QOL) and fatigue.
QUALITY OF LIFE SUBSTUDY OBJECTIVE:
I. To compare overall quality of life, disease-related symptoms, and other domains between the two treatment groups (cabozantinib versus [vs.] placebo) within each cohort of patients (pancreatic NET vs. carcinoid tumor). (Quality of Life Substudy Objective - A021602-HO1)
POPULATION PHARMACOKINETICS SUBSTUDY OBJECTIVE:
I. To describe the population pharmacokinetic and exposure-response relationships of cabozantinib in patients with advanced neuroendocrine tumors. (Population Pharmacokinetics Substudy Objective - A021602-PP1)
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive cabozantinib S-malate orally (PO) once daily (QD) on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and computed tomography (CT), magnetic resonance imaging (MRI), and/or x-ray imaging during screening and on study.
ARM II: Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.
After completion of study treatment, patients are followed up every 12 weeks until disease progression or start of new anticancer therapy, and then every 6 months until 8 years after registration.
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 3
Kontakty a umístění
Studijní místa
-
-
Alaska
-
Anchorage, Alaska, Spojené státy, 99508
- Katmai Oncology Group
-
-
Arizona
-
Kingman, Arizona, Spojené státy, 86401
- Kingman Regional Medical Center
-
Phoenix, Arizona, Spojené státy, 85054
- Mayo Clinic Hospital in Arizona
-
Tucson, Arizona, Spojené státy, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Spojené státy, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock, Arkansas, Spojené státy, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, Spojené státy, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Arroyo Grande, California, Spojené státy, 93420
- PCR Oncology
-
Auburn, California, Spojené státy, 95602
- Sutter Auburn Faith Hospital
-
Berkeley, California, Spojené státy, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Spojené státy, 94010
- Mills-Peninsula Medical Center
-
Duarte, California, Spojené státy, 91010
- City of Hope Comprehensive Cancer Center
-
Dublin, California, Spojené státy, 94568
- Epic Care-Dublin
-
Emeryville, California, Spojené státy, 94608
- Epic Care Partners in Cancer Care
-
Fremont, California, Spojené státy, 94538
- Kaiser Permanente-Fremont
-
Fremont, California, Spojené státy, 94538
- Palo Alto Medical Foundation-Fremont
-
Fresno, California, Spojené státy, 93720
- Kaiser Permanente-Fresno
-
Martinez, California, Spojené státy, 94553-3156
- Contra Costa Regional Medical Center
-
Marysville, California, Spojené státy, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Spojené státy, 95355
- Memorial Medical Center
-
Modesto, California, Spojené státy, 95356
- Kaiser Permanente-Modesto
-
Mountain View, California, Spojené státy, 94040
- Palo Alto Medical Foundation-Camino Division
-
Oakland, California, Spojené státy, 94611
- Kaiser Permanente-Oakland
-
Oakland, California, Spojené státy, 94609
- Alta Bates Summit Medical Center - Summit Campus
-
Palo Alto, California, Spojené státy, 94304
- Stanford Cancer Institute Palo Alto
-
Palo Alto, California, Spojené státy, 94301
- Palo Alto Medical Foundation Health Care
-
Redwood City, California, Spojené státy, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Spojené státy, 94801
- Kaiser Permanente-Richmond
-
Roseville, California, Spojené státy, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, Spojené státy, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Spojené státy, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Spojené státy, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Spojené státy, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Spojené státy, 95823
- Kaiser Permanente-South Sacramento
-
Salinas, California, Spojené státy, 93901
- Salinas Valley Memorial
-
San Francisco, California, Spojené státy, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Spojené státy, 94158
- UCSF Medical Center-Mission Bay
-
San Francisco, California, Spojené státy, 94115
- California Pacific Medical Center-Pacific Campus
-
San Jose, California, Spojené státy, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Spojené státy, 94577
- Kaiser Permanente San Leandro
-
San Mateo, California, Spojené státy, 94401
- Mills Health Center
-
San Rafael, California, Spojené státy, 94903
- Kaiser San Rafael-Gallinas
-
San Rafael, California, Spojené státy, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Spojené státy, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Cruz, California, Spojené státy, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Santa Rosa, California, Spojené státy, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, Spojené státy, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Spojené státy, 95210
- Kaiser Permanente-Stockton
-
Sunnyvale, California, Spojené státy, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Vacaville, California, Spojené státy, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Spojené státy, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Spojené státy, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, Spojené státy, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Spojené státy, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Boulder, Colorado, Spojené státy, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, Spojené státy, 80907
- Penrose-Saint Francis Healthcare
-
Denver, Colorado, Spojené státy, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Spojené státy, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Spojené státy, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Spojené státy, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Englewood, Colorado, Spojené státy, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Spojené státy, 80113
- Swedish Medical Center
-
Golden, Colorado, Spojené státy, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Spojené státy, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Spojené státy, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, Spojené státy, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Littleton, Colorado, Spojené státy, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Spojené státy, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Spojené státy, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Spojené státy, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Spojené státy, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Danbury, Connecticut, Spojené státy, 06810
- Danbury Hospital
-
Norwalk, Connecticut, Spojené státy, 06856
- Norwalk Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Spojené státy, 20007
- MedStar Georgetown University Hospital
-
-
Florida
-
Aventura, Florida, Spojené státy, 33180
- GenesisCare USA - Aventura FP
-
Aventura, Florida, Spojené státy, 33180
- GenesisCare USA - Aventura
-
Boca Raton, Florida, Spojené státy, 33431
- GenesisCare USA - Boca Ration FP06
-
Fort Myers, Florida, Spojené státy, 33905
- Regional Cancer Center-Lee Memorial Health System
-
Hollywood, Florida, Spojené státy, 33021
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital
-
Jacksonville, Florida, Spojené státy, 32224-9980
- Mayo Clinic in Florida
-
Tampa, Florida, Spojené státy, 33612
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Spojené státy, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Spojené státy, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Spojené státy, 30342
- Emory Saint Joseph's Hospital
-
-
Hawaii
-
Honolulu, Hawaii, Spojené státy, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Spojené státy, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Spojené státy, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Spojené státy, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Spojené státy, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Spojené státy, 96819
- Kaiser Permanente Moanalua Medical Center
-
‘Aiea, Hawaii, Spojené státy, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Spojené státy, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, Spojené státy, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Spojené státy, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Spojené státy, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Spojené státy, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Spojené státy, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Spojené státy, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Spojené státy, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Spojené státy, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Spojené státy, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Spojené státy, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Spojené státy, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Spojené státy, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Spojené státy, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Spojené státy, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Spojené státy, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Spojené státy, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, Spojené státy, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Spojené státy, 60612
- University of Illinois
-
Danville, Illinois, Spojené státy, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Spojené státy, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Spojené státy, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Spojené státy, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Spojené státy, 62401
- Carle Physician Group-Effingham
-
Eureka, Illinois, Spojené státy, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Spojené státy, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, Spojené státy, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Spojené státy, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Spojené státy, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, Spojené státy, 60153
- Loyola University Medical Center
-
New Lenox, Illinois, Spojené státy, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
O'Fallon, Illinois, Spojené státy, 62269
- Cancer Care Center of O'Fallon
-
Orland Park, Illinois, Spojené státy, 60462
- University of Chicago Medicine-Orland Park
-
Ottawa, Illinois, Spojené státy, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Spojené státy, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Spojené státy, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Spojené státy, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Spojené státy, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Spojené státy, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Spojené státy, 62702
- Springfield Clinic
-
Urbana, Illinois, Spojené státy, 61801
- Carle Cancer Center
-
Washington, Illinois, Spojené státy, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
South Bend, Indiana, Spojené státy, 46601
- Memorial Hospital of South Bend
-
-
Iowa
-
Bettendorf, Iowa, Spojené státy, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Cedar Rapids, Iowa, Spojené státy, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, Spojené státy, 52403
- Oncology Associates at Mercy Medical Center
-
Clive, Iowa, Spojené státy, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Spojené státy, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Council Bluffs, Iowa, Spojené státy, 51503
- Heartland Oncology and Hematology LLP
-
Council Bluffs, Iowa, Spojené státy, 51503
- Methodist Jennie Edmundson Hospital
-
Creston, Iowa, Spojené státy, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Spojené státy, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Spojené státy, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Spojené státy, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Spojené státy, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Spojené státy, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Spojené státy, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Spojené státy, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines, Iowa, Spojené státy, 50266
- Mercy Medical Center-West Lakes
-
-
Kentucky
-
Lexington, Kentucky, Spojené státy, 40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, Spojené státy, 70808
- Our Lady of The Lake
-
Baton Rouge, Louisiana, Spojené státy, 70808
- Our Lady of the Lake Physician Group
-
Covington, Louisiana, Spojené státy, 70433
- Northshore Oncology Associates-Covington
-
Houma, Louisiana, Spojené státy, 70360
- Oncology Center of The South Incorporated
-
-
Massachusetts
-
Boston, Massachusetts, Spojené státy, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Spojené státy, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Spojené státy, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Spojené státy, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Spojené státy, 01805
- Lahey Clinic
-
-
Michigan
-
Adrian, Michigan, Spojené státy, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Spojené státy, 48109
- University of Michigan Rogel Cancer Center
-
Ann Arbor, Michigan, Spojené státy, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Spojené státy, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Spojené státy, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Spojené státy, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Spojené státy, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Spojené státy, 48188
- Trinity Health Medical Center - Canton
-
Caro, Michigan, Spojené státy, 48723
- Caro Cancer Center
-
Chelsea, Michigan, Spojené státy, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Spojené státy, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Spojené státy, 48346
- McLaren Cancer Institute-Clarkston
-
Clarkston, Michigan, Spojené státy, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Spojené státy, 48346
- Newland Medical Associates-Clarkston
-
Detroit, Michigan, Spojené státy, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Spojené státy, 48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit, Michigan, Spojené státy, 48236
- Henry Ford Health Saint John Hospital
-
East China Township, Michigan, Spojené státy, 48054
- Henry Ford River District Hospital
-
Farmington Hills, Michigan, Spojené státy, 48334
- Weisberg Cancer Treatment Center
-
Flint, Michigan, Spojené státy, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, Spojené státy, 48532
- Singh and Arora Hematology Oncology PC
-
Flint, Michigan, Spojené státy, 48503
- Hurley Medical Center
-
Flint, Michigan, Spojené státy, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Spojené státy, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Spojené státy, 48503
- Cancer Hematology Centers - Flint
-
Grosse Pointe Woods, Michigan, Spojené státy, 48236
- Henry Ford Saint John Hospital - Academic
-
Grosse Pointe Woods, Michigan, Spojené státy, 48236
- Henry Ford Saint John Hospital - Breast
-
Grosse Pointe Woods, Michigan, Spojené státy, 48236
- Henry Ford Saint John Hospital - Van Elslander
-
Kalamazoo, Michigan, Spojené státy, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Spojené státy, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Spojené státy, 49009
- Beacon Kalamazoo Cancer Center
-
Lansing, Michigan, Spojené státy, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, Spojené státy, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Spojené státy, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Spojené státy, 48154
- Hope Cancer Clinic
-
Macomb, Michigan, Spojené státy, 48044
- Henry Ford Warren Hospital - Breast Macomb
-
Macomb, Michigan, Spojené státy, 48044
- Henry Ford Saint John Hospital - Macomb Medical
-
Marlette, Michigan, Spojené státy, 48453
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Monroe, Michigan, Spojené státy, 48162
- Toledo Clinic Cancer Centers-Monroe
-
Mount Clemens, Michigan, Spojené státy, 48043
- McLaren Cancer Institute-Macomb
-
Mount Pleasant, Michigan, Spojené státy, 48858
- McLaren Cancer Institute-Central Michigan
-
Petoskey, Michigan, Spojené státy, 49770
- McLaren Cancer Institute-Northern Michigan
-
Pontiac, Michigan, Spojené státy, 48341
- Hope Cancer Center
-
Pontiac, Michigan, Spojené státy, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Spojené státy, 48341
- Michigan Healthcare Professionals Pontiac
-
Pontiac, Michigan, Spojené státy, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Port Huron, Michigan, Spojené státy, 48060
- McLaren-Port Huron
-
Port Huron, Michigan, Spojené státy, 48060
- Lake Huron Medical Center
-
Port Huron, Michigan, Spojené státy, 48060
- Huron Medical Center PC
-
Rochester Hills, Michigan, Spojené státy, 48309
- Henry Ford Rochester Hospital
-
Saginaw, Michigan, Spojené státy, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Spojené státy, 48601
- MyMichigan Medical Center Saginaw
-
Sterling Heights, Michigan, Spojené státy, 48312
- Bhadresh Nayak MD PC-Sterling Heights
-
Tawas City, Michigan, Spojené státy, 48764
- MyMichigan Medical Center Tawas
-
Warren, Michigan, Spojené státy, 48088
- Advanced Breast Care Center PLLC
-
Warren, Michigan, Spojené státy, 48093
- Macomb Hematology Oncology PC
-
Warren, Michigan, Spojené státy, 48093
- Henry Ford Madison Heights Hospital - Breast
-
Warren, Michigan, Spojené státy, 48093
- Henry Ford Health Warren Hospital
-
Warren, Michigan, Spojené státy, 48093
- Henry Ford Warren Hospital - GLCMS
-
West Branch, Michigan, Spojené státy, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Ypsilanti, Michigan, Spojené státy, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Ypsilanti, Michigan, Spojené státy, 48106
- Huron Gastroenterology PC
-
-
Minnesota
-
Bemidji, Minnesota, Spojené státy, 56601
- Sanford Joe Lueken Cancer Center
-
Burnsville, Minnesota, Spojené státy, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, Spojené státy, 55337
- Minnesota Oncology - Burnsville
-
Coon Rapids, Minnesota, Spojené státy, 55433
- Mercy Hospital
-
Deer River, Minnesota, Spojené státy, 56636
- Essentia Health - Deer River Clinic
-
Duluth, Minnesota, Spojené státy, 55805
- Essentia Health Cancer Center
-
Edina, Minnesota, Spojené státy, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, Spojené státy, 55432
- Unity Hospital
-
Hibbing, Minnesota, Spojené státy, 55746
- Essentia Health Hibbing Clinic
-
Maple Grove, Minnesota, Spojené státy, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Spojené státy, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Spojené státy, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Spojené státy, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Spojené státy, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Spojené státy, 55454
- Health Partners Inc
-
New Ulm, Minnesota, Spojené státy, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Spojené státy, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, Spojené státy, 55905
- Mayo Clinic in Rochester
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Spojené státy, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Spojené státy, 55102
- United Hospital
-
Sandstone, Minnesota, Spojené státy, 55072
- Essentia Health Sandstone
-
Shakopee, Minnesota, Spojené státy, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Spojené státy, 55082
- Lakeview Hospital
-
Virginia, Minnesota, Spojené státy, 55792
- Essentia Health Virginia Clinic
-
Waconia, Minnesota, Spojené státy, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Spojené státy, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Spojené státy, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, Spojené státy, 55092
- Fairview Lakes Medical Center
-
-
Missouri
-
Bonne Terre, Missouri, Spojené státy, 63628
- Parkland Health Center-Bonne Terre
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Saint Francis Medical Center
-
City of Saint Peters, Missouri, Spojené státy, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur, Missouri, Spojené státy, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, Spojené státy, 63640
- Parkland Health Center - Farmington
-
Sainte Genevieve, Missouri, Spojené státy, 63670
- Sainte Genevieve County Memorial Hospital
-
St Louis, Missouri, Spojené státy, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Spojené státy, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, Spojené státy, 63136
- Siteman Cancer Center at Christian Hospital
-
St Louis, Missouri, Spojené státy, 63131
- Missouri Baptist Medical Center
-
Sullivan, Missouri, Spojené státy, 63080
- Missouri Baptist Sullivan Hospital
-
-
Montana
-
Anaconda, Montana, Spojené státy, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Spojené státy, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Spojené státy, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Spojené státy, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Spojené státy, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Spojené státy, 59405
- Great Falls Clinic
-
Great Falls, Montana, Spojené státy, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Spojené státy, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Spojené státy, 59901
- Logan Health Medical Center
-
Missoula, Montana, Spojené státy, 59804
- Community Medical Center
-
-
Nebraska
-
Grand Island, Nebraska, Spojené státy, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Omaha, Nebraska, Spojené státy, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Spojené státy, 68114
- Oncology Associates PC
-
Omaha, Nebraska, Spojené státy, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
-
Nevada
-
Carson City, Nevada, Spojené státy, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, Spojené státy, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Spojené státy, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Spojené státy, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Spojené státy, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Spojené státy, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Spojené státy, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Spojené státy, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Spojené státy, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Spojené státy, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Spojené státy, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Spojené státy, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Spojené státy, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Spojené státy, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Spojené státy, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Spojené státy, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, Spojené státy, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Spojené státy, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Spojené státy, 89121
- Cancer Therapy and Integrative Medicine
-
Las Vegas, Nevada, Spojené státy, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, Spojené státy, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Spojené státy, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Spojené státy, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Spojené státy, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Spojené státy, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Spojené státy, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Spojené státy, 89169
- University Cancer Center
-
Las Vegas, Nevada, Spojené státy, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, Spojené státy, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, Spojené státy, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Spojené státy, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Spojené státy, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, Spojené státy, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon, New Hampshire, Spojené státy, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Nashua, New Hampshire, Spojené státy, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Basking Ridge, New Jersey, Spojené státy, 07920
- Memorial Sloan Kettering Basking Ridge
-
Englewood, New Jersey, Spojené státy, 07631
- Englewood Hospital and Medical Center
-
Middletown, New Jersey, Spojené státy, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Spojené státy, 07645
- Memorial Sloan Kettering Bergen
-
Paramus, New Jersey, Spojené státy, 07652
- The Valley Hospital - Luckow Pavilion
-
Ridgewood, New Jersey, Spojené státy, 07450
- Valley Health System Ridgewood Campus
-
Wayne, New Jersey, Spojené státy, 07470
- Valley Medical Group - Wayne Multispecialty Practice
-
-
New Mexico
-
Albuquerque, New Mexico, Spojené státy, 87109
- New Mexico Oncology Hematology Consultants
-
Albuquerque, New Mexico, Spojené státy, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Spojené státy, 87110
- Presbyterian Kaseman Hospital
-
Rio Rancho, New Mexico, Spojené státy, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Auburn, New York, Spojené státy, 13021
- Hematology Oncology Associates of Central New York-Auburn
-
Buffalo, New York, Spojené státy, 14263
- Roswell Park Cancer Institute
-
Camillus, New York, Spojené státy, 13031
- Hematology Oncology Associates of CNY at Camillus
-
Commack, New York, Spojené státy, 11725
- Memorial Sloan Kettering Commack
-
East Syracuse, New York, Spojené státy, 13057
- Hematology Oncology Associates of Central New York-East Syracuse
-
Harrison, New York, Spojené státy, 10604
- Memorial Sloan Kettering Westchester
-
New York, New York, Spojené státy, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Spojené státy, 10029
- Mount Sinai Hospital
-
Rochester, New York, Spojené státy, 14642
- University of Rochester
-
Uniondale, New York, Spojené státy, 11553
- Memorial Sloan Kettering Nassau
-
Webster, New York, Spojené státy, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Chapel Hill, North Carolina, Spojené státy, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Clinton, North Carolina, Spojené státy, 28328
- Southeastern Medical Oncology Center-Clinton
-
Goldsboro, North Carolina, Spojené státy, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Hendersonville, North Carolina, Spojené státy, 28791
- Margaret R Pardee Memorial Hospital
-
Jacksonville, North Carolina, Spojené státy, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Kinston, North Carolina, Spojené státy, 28501
- ECU Health Oncology Kinston
-
Washington, North Carolina, Spojené státy, 27889
- Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
-
-
North Dakota
-
Bismarck, North Dakota, Spojené státy, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood, Ohio, Spojené státy, 44122
- UHHS-Chagrin Highlands Medical Center
-
Belpre, Ohio, Spojené státy, 45714
- Strecker Cancer Center-Belpre
-
Centerville, Ohio, Spojené státy, 45459
- Miami Valley Hospital South
-
Chillicothe, Ohio, Spojené státy, 45601
- Adena Regional Medical Center
-
Cleveland, Ohio, Spojené státy, 44106
- Case Western Reserve University
-
Columbus, Ohio, Spojené státy, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Spojené státy, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Spojené státy, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Spojené státy, 43228
- Doctors Hospital
-
Columbus, Ohio, Spojené státy, 43215
- Grant Medical Center
-
Dayton, Ohio, Spojené státy, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Spojené státy, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Spojené státy, 45409
- Premier Blood and Cancer Center
-
Delaware, Ohio, Spojené státy, 43015
- Delaware Health Center-Grady Cancer Center
-
Franklin, Ohio, Spojené státy, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Mansfield, Ohio, Spojené státy, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Spojené státy, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, Spojené státy, 43302
- OhioHealth Marion General Hospital
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Spojené státy, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mentor, Ohio, Spojené státy, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, Spojené státy, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Newark, Ohio, Spojené státy, 43055
- Licking Memorial Hospital
-
Parma, Ohio, Spojené státy, 44129
- University Hospitals Parma Medical Center
-
Perrysburg, Ohio, Spojené státy, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, Spojené státy, 45662
- Southern Ohio Medical Center
-
Toledo, Ohio, Spojené státy, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Spojené státy, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Troy, Ohio, Spojené státy, 45373
- Upper Valley Medical Center
-
Wadsworth, Ohio, Spojené státy, 44281
- University Hospitals Sharon Health Center
-
Westlake, Ohio, Spojené státy, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Zanesville, Ohio, Spojené státy, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Spojené státy, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Baker City, Oregon, Spojené státy, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Clackamas, Oregon, Spojené státy, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Spojené státy, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Spojené státy, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Portland, Oregon, Spojené státy, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Spojené státy, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Spojené státy, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Bethlehem, Pennsylvania, Spojené státy, 18017
- Lehigh Valley Hospital - Muhlenberg
-
East Stroudsburg, Pennsylvania, Spojené státy, 18301
- Pocono Medical Center
-
Erie, Pennsylvania, Spojené státy, 16544
- Saint Vincent Hospital
-
Hazleton, Pennsylvania, Spojené státy, 18201
- Lehigh Valley Hospital-Hazleton
-
Jefferson Hills, Pennsylvania, Spojené státy, 15025
- Jefferson Hospital
-
Monroeville, Pennsylvania, Spojené státy, 15146
- Forbes Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Spojené státy, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Spojené státy, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, Spojené státy, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Spojené státy, 15224
- West Penn Hospital
-
Wexford, Pennsylvania, Spojené státy, 15090
- Wexford Health and Wellness Pavilion
-
-
South Carolina
-
Boiling Springs, South Carolina, Spojené státy, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Spojené státy, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Spojené státy, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Spojené státy, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Spojené státy, 29672
- Prisma Health Cancer Institute - Seneca
-
-
South Dakota
-
Sioux Falls, South Dakota, Spojené státy, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Spojené státy, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Utah
-
Farmington, Utah, Spojené státy, 84025
- Farmington Health Center
-
Salt Lake City, Utah, Spojené státy, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Spojené státy, 84106
- University of Utah Sugarhouse Health Center
-
-
Washington
-
Seattle, Washington, Spojené státy, 98101
- Virginia Mason Medical Center
-
-
West Virginia
-
Huntington, West Virginia, Spojené státy, 25701
- Edwards Comprehensive Cancer Center
-
Morgantown, West Virginia, Spojené státy, 26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Appleton, Wisconsin, Spojené státy, 54911
- ThedaCare Regional Cancer Center
-
Ashland, Wisconsin, Spojené státy, 54806
- Duluth Clinic Ashland
-
Eau Claire, Wisconsin, Spojené státy, 54701
- Marshfield Medical Center-EC Cancer Center
-
Madison, Wisconsin, Spojené státy, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center-Marshfield
-
Minocqua, Wisconsin, Spojené státy, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Spojené státy, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Spojené státy, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Spojené státy, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Rice Lake, Wisconsin, Spojené státy, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Spojené státy, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Waukesha, Wisconsin, Spojené státy, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Spojené státy, 53188
- ProHealth Waukesha Memorial Hospital
-
Weston, Wisconsin, Spojené státy, 54476
- Marshfield Medical Center - Weston
-
-
Wyoming
-
Cody, Wyoming, Spojené státy, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Spojené státy, 82801
- Welch Cancer Center
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
-
Documentation of Disease:
-
Histologic Documentation: Well- or moderately-differentiated neuroendocrine tumors of pancreatic and non-pancreatic (i.e. carcinoid) origin by local pathology
- The pathology report must state ONE of the following: 1) well- or moderately-differentiated neuroendocrine tumor, 2) low- or intermediate-grade neuroendocrine tumor, or 3) carcinoid tumor or atypical carcinoid tumor; documentation of histology from a primary or metastatic site is allowed
- Patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma without specification of differentiation status, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible. Patients with well-differentiated grade 3 neuroendocrine tumor are eligible
-
Stage: Locally advanced/unresectable or metastatic disease
-
Tumor Site: Histological documentation of neuroendocrine tumor of pancreatic, gastrointestinal (GI), lung, thymus, other, or unknown primary site; GI, lung, thymus, other, and unknown primary NETs will enroll in the carcinoid tumor cohort of the study
- Functional (i.e., associated with symptoms or clinical syndrome related to hormone secretion by tumor) or nonfunctional tumors are allowed
-
Radiologic Evaluation: Target lesions must have shown evidence of disease progression by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 criteria in the 12 months prior to registration; the radiologic images, imaging reports, and clinic notes indicating growth of existing lesions, development of new lesions, or treatment changes must be submitted
-
-
Measurable Disease
- Patients must have measurable disease per RECIST 1.1 by computer tomography (CT) scan or magnetic resonance imaging (MRI)
- Lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); non-measurable disease includes disease smaller than these dimensions or lesions considered truly non-measurable including: leptomeningeal disease, ascites, pleural or pericardial effusion, lymphangitic involvement of skin or lung
-
Prior Treatment
- Patient must have experienced disease progression after receiving or intolerance leading to treatment discontinuation of at least one Food and Drug Administration (FDA)-approved line of therapy (except somatostatin analogs); prior lines of therapy must include one of the following: everolimus, sunitinib, or lutetium Lu 177 dotatate in patients with pancreatic NET; everolimus in patients with lung NET; everolimus or lutetium Lu 177 dotatate in patients with gastrointestinal NET
- Prior treatment (except somatostatin analogs) with biologic therapy, immunotherapy, chemotherapy, investigational agent for malignancy, and/or radiation must be completed at least 28 days prior to registration
- Prior treatment with somatostatin analogs is allowed, and continuation of treatment with somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
- Prior systemic treatment with radionuclide therapy must be completed at least 6 weeks prior to registration
- Prior treatment with hepatic artery embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or if there is documented disease progression in a treated site; prior liver-directed or other ablative treatment must be completed at least 28 days prior to registration
- Prior treatment with cabozantinib is not allowed
- Patients should have resolution of any toxic effects of prior therapy (except alopecia and fatigue) to National Cancer Institute (NCI) CTCAE, version 5.0, grade 1 or less
- Patients must have completed any major surgery at least 12 weeks prior to registration and any minor surgery (including uncomplicated tooth extractions) at least 28 days prior to registration; complete wound healing from major surgery must have occurred at least 28 days prior to registration, and complete wound healing from minor surgery must have occurred at least 10 days prior to registration
-
Patient History
- No class III or IV congestive heart failure (CHF) within 6 months of registration
- No clinically significant cardiac arrhythmia within 6 months of registration
- No unstable angina or myocardial infarction (MI) within 6 months of registration
- No thromboembolic events within 6 months of registration (including [incl.] stroke, transient ischemic attack [TIA], deep vein thrombosis [DVT], & pulmonary embolism [PE])
- No known history of congenital long QT syndrome
- No uncontrolled hypertension within 14 days of registration (defined as systolic blood pressure [SBP] >= 150 mmHg and/or diastolic blood pressure [DBP] >= 90 mmHg despite optimal medical management)
- No clinically significant GI bleeding within 6 months of registration
- No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 6 months of registration including, but not limited to: active peptic ulcer, known endoluminal metastatic lesion(s) with history of bleeding, inflammatory bowel disease, or other gastrointestinal conditions with increased risk of perforation
- No GI perforation within 6 months of registration
- No known tumor with invasion into the GI tract from the outside causing increased risk of perforation or bleeding within 28 days of registration
- No radiologic or clinical evidence of pancreatitis
- No known cavitary lung lesions
- No known endobronchial lesions involving the main or lobar bronchi and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; (CT with contrast is recommended to evaluate such lesions)
- No hemoptysis greater than 1/2 teaspoon (2.5 mL) or any other signs of pulmonary hemorrhage within the 3 months prior to registration
- No known tumor invading or encasing any major blood vessels
- No history of non-healing wounds or ulcers within 28 days of registration
- No history of fracture within 28 days of registration
- No brain metastases or cranial epidural disease unless adequately treated, stable, and off steroid support for at least 4 weeks prior to registration
- No known medical condition causing an inability to swallow oral formulations of agents
- No history of allergic reaction attributed to compounds of similar chemical or biological composition to cabozantinib/placebo
- No "currently active" second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ; patients are not considered to have a "currently active" malignancy if they have completed therapy and are free of disease for >= 3 years
-
Concomitant Medications
- Other planned concurrent investigational agents or other tumor directed therapies (chemotherapy, radiation) are not allowed while on this study
- Concurrent use of somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months
- Full dose oral anticoagulation/antiplatelet therapy is not permitted; low dose aspirin =< 81 mg/day is allowed; anticoagulation with therapeutic doses of low molecular weight heparin (LMWH) is allowed in patients who are on a stable dose of LMWH for at least 6 weeks prior to registration; treatment with warfarin is not allowed; anticoagulation in patients with brain metastases is not permitted
- Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
- Chronic concomitant treatment with strong CYP3A4 inducers is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study
-
Not pregnant and not nursing
- Women of childbearing potential must have a negative pregnancy test done =< 14 days prior to registration
- A female of childbearing potential is a sexually mature female who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 12 consecutive months (i.e. has had menses at any time in the preceding 12 consecutive months)
-
Age >= 18 years
-
Eastern Cooperative Oncology Group (ECOG) performance status: 0-2
-
Absolute neutrophil count (ANC) >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelet count >= 100,000/mm^3
-
Prothrombin time (PT)/ international normalized ratio (INR), partial thromboplastin time (PTT) < 1.3 x upper limit of normal (ULN)
-
Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) =< 3 x ULN
-
Total bilirubin =< 1.5 x ULN
- Except in the case of Gilbert disease, in which case total bilirubin must be =< 3 x ULN
-
Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45 mL/min
-
Albumin >= 2.8 g/dL
-
Potassium within normal limits (WNL)
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal thyroid stimulating hormone (TSH), if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Phosphorus WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Calcium WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Magnesium WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
-
Urine protein to creatinine (UPC) ratio =< 1
-
QT interval corrected for heart rate using Fridericia's formula (QTcF) =< 500 msec
-
TSH WNL
- Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Arm I (cabozantinib S-malate)
Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. |
Ancillary studies
Ostatní jména:
Undergo CT
Ostatní jména:
Undergo MRI
Ostatní jména:
Given PO
Ostatní jména:
Undergo blood and urine sample collection
Ostatní jména:
Undergo x-ray
Ostatní jména:
|
|
Komparátor placeba: Arm II (placebo)
Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression. |
Ancillary studies
Ostatní jména:
Undergo CT
Ostatní jména:
Undergo MRI
Ostatní jména:
Given PO Undergo blood and urine sample collection
Ostatní jména:
Undergo x-ray
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Progression-free Survival (PFS)
Časové okno: 36 months
|
Will be assessed per Response Evaluation Criteria in Solid Tumors 1.1 determined by retrospective independent central review. Will be compared between treatment arms using the stratified log rank test at one-sided level 0.025. The stratification factors will be used for the analysis. The hazard ratio (HR) for PFS will be estimated using a stratified Cox proportional hazards model, and the 95% confidence interval (CI) for the HR will be provided. Results from an unstratified analysis will also be provided. Kaplan-Meier methodology will be used to estimate the median PFS for each treatment arm, and Kaplan-Meier curves will be produced. Brookmeyer Crowley methodology will be used to construct the 95% CI for the median PFS for each treatment arm. |
36 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Overall Survival (OS)
Časové okno: 60 months
|
The analyses for OS will follow intent-to-treat (ITT) principle and will be conducted separately within each cohort (pancreatic neuroendocrine tumor [NET] and carcinoid tumor). The distribution of OS will be estimated using the method of Kaplan-Meier. The median OS, along with the 95% CI, will be estimated by the two treatment groups. Overall survival will be compared between treatment arms using the stratified log-rank test at a one-sided cumulative 2.5% level of significance. The stratified Cox regression will be used to estimate the HR of OS, along with the 95% CI. A hierarchical approach will be used to control for family-wise type-I error rate, therefore OS will be formally statistically tested only if the primary efficacy endpoint, PFS, is statistically significantly different between the two treatment groups. |
60 months
|
|
Number of Patients Experiencing Grade 3+ Adverse Events (AEs) Graded According to the Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Časové okno: 60 months
|
For CTCAE data, the frequency tables will be reviewed to determine the patterns. The overall adverse event rates will be compared between treatment groups using Chi-square test (or Fisher's exact test if the data in contingency table is sparse). PRO-CTCAE data will, at minimum, be analyzed similarly to CTCAE data. The initial analysis of each PRO-CTCAE item will use all available scores in an analysis which mirrors the approach used for the CTCAE data. Supplemental analysis will use model-based multiple imputation incorporating baseline patient characteristics and physician-rated performance status. CTCAE data may be incorporated as auxiliary data into multiple imputation models for AEs which are captured by both PRO-CTCAE and CTCAE. Results from supplemental analysis will be descriptively compared to the results of the initial analysis to assess the robustness of results to missing data. Additional analyses of PRO-CTCAE data beyond those specified above may be undertaken. |
60 months
|
|
Radiographic Response Rate
Časové okno: 36 months
|
Will be defined as the proportion of patients in each arm whose best response is either complete response (CR) or partial response (PR). Radiographic response rate for both cohorts: the analyses for confirmed radiographic response rate will follow the ITT principle and will be conducted separately within each cohort (pancreatic NET and carcinoid tumor). The proportion of patients with either confirmed CR or confirmed PR as their best response will be estimated using point estimates and 95% confidence intervals. Radiographic response rate will be compared between treatment arms using the 2-sample z-test to compare sample proportion at a one-sided 2.5% level of significance. |
36 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Jennifer A Chan, Alliance for Clinical Trials in Oncology
Publikace a užitečné odkazy
Obecné publikace
- Kunz PL. Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age. Lancet Oncol. 2020 Nov;21(11):1395-1397. doi: 10.1016/S1470-2045(20)30560-X. No abstract available.
- Chan JA, Geyer S, Zemla T, Knopp MV, Behr S, Pulsipher S, Ou FS, Dueck AC, Acoba J, Shergill A, Wolin EM, Halfdanarson TR, Konda B, Trikalinos NA, Tawfik B, Raj N, Shaheen S, Vijayvergia N, Dasari A, Strosberg JR, Kohn EC, Kulke MH, O'Reilly EM, Meyerhardt JA. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13;392(7):653-665. doi: 10.1056/NEJMoa2403991. Epub 2024 Sep 16.
- Strosberg JR, Zemla T, Geyer S, Pulsipher S, Ou FS, Behr S, Raj N, Vijayvergia N, Dasari A, O'Reilly EM, Meyerhardt JA, Wolin EM, Halfdanarson TR, Chan JA. Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602). Endocr Relat Cancer. 2026 Jan 24;33(1):e250415. doi: 10.1530/ERC-25-0415. Print 2026 Jan 1.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Onemocnění endokrinního systému
- Novotvary podle místa
- Novotvary
- Novotvary podle histologického typu
- Novotvary trávicího systému
- Nemoci trávicího systému
- Novotvary endokrinních žláz
- Onemocnění slinivky břišní
- Novotvary, žlázové a epiteliální
- Adenom
- Neuroektodermální nádory
- Novotvary, zárodečné buňky a embryonální
- Novotvary, nervová tkáň
- Novotvary pankreatu
- Neuroendokrinní nádory
- Adenom, Islet Cell
- Nefunkční endokrinní nádor pankreatu
- Vyšetřovací techniky
- Klinické laboratorní techniky
- Diagnostické techniky a postupy
- Diagnóza
- Fyzické jevy
- Vybavení a potřeby
- Techniky chemie, analytické
- Analýza spektra
- Elektromagnetické jevy
- Magnetické jevy
- Elektromagnetické záření
- Záření
- Záření, ionizující
- Manipulace se vzorkem
- Magnetická rezonanční spektroskopie
- Rentgenové paprsky
- Cabozantinib
- Phantomy, zobrazování
Další identifikační čísla studie
- NCI-2017-02297
- U10CA180821 (Grant/smlouva NIH USA)
- NCI-2017-02297 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
- A021602 (Jiný identifikátor: CTEP)
- A021602 (Jiný identifikátor: Alliance for Clinical Trials in Oncology)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .